Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.

CNS Neurol Disord Drug Targets • March 11, 2026 Peer reviewed • DOI: 10.2174/0118715273434237251212095005 • via PubMed